MEDI6570 is an antibody of the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) that is being tested in people with type 2 diabetes to see if it…
MEDI6570 is an antibody of the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) that is being tested in people with type 2 diabetes to see if it reduces their risk of cardiovascular disease. The drug is developed by AstraZeneca.
References
Gebaseerd op: Wikipedia — MEDI6570 · auteursgeschiedenis.
Tekst: CC BY-SA 4.0.
Wikisyntaxis en sjablonen zijn verwijderd; langere teksten zijn ingekort.